Edition:
United States

Precipio Inc (PRPO.OQ)

PRPO.OQ on NASDAQ Stock Exchange Capital Market

0.42USD
21 Sep 2018
Change (% chg)

$0.01 (+2.04%)
Prev Close
$0.41
Open
$0.43
Day's High
$0.43
Day's Low
$0.40
Volume
35,813
Avg. Vol
171,925
52-wk High
$2.64
52-wk Low
$0.32

Chart for

About

Precipio, Inc., formerly Transgenomic, Inc., is a biotechnology company. The Company is engaged in advancing personalized medicine for the detection and treatment of cancer, and inherited diseases through its molecular technologies and clinical and research services. The Company operates through its Laboratory Services segment.... (more)

Overall

Beta: 0.32
Market Cap(Mil.): $9.73
Shares Outstanding(Mil.): 23.16
Dividend: --
Yield (%): --

Financials

  PRPO.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -3.22 -- --
ROI: -109.82 1.50 12.72
ROE: -197.80 0.19 14.85

BRIEF-Precipio Announces "Accelerating" Sales Of Its Pathology Services In April

* PRECIPIO INC - ACCELERATING SALES OF ITS PATHOLOGY SERVICES IN APRIL, INDICATING ANTICIPATED SEQUENTIAL DOUBLE DIGIT QUARTERLY SALES GROWTH

May 22 2018

BRIEF-Precipio Launches Ice Cold-Pcr™ Liquid Biopsy Kit For Pancreatic Cancer

* PRECIPIO LAUNCHES ICE COLD-PCR™ LIQUID BIOPSY KIT FOR PANCREATIC CANCER

May 17 2018

BRIEF-Precipio Inc Files For Non-Timely 10-Q

* PRECIPIO INC FILES FOR NON-TIMELY 10-Q WITH U.S. SEC Source http://bit.ly/2IJcN8g Further company coverage:

May 15 2018

BRIEF-Precipio In Strategic Partnership Discussions For Proprietary Cytogenetics Media IV-Cell

* PRECIPIO IN STRATEGIC PARTNERSHIP DISCUSSIONS FOR PROPRIETARY CYTOGENETICS MEDIA IV-CELL

Apr 18 2018

BRIEF-Precipio - Responses To Articles, On Its Approach Using Ice Cold-Pcr Liquid Biopsy Tests On Real Time Pcr Platforms ‍​

* PRECIPIO - RESPONSES TO ARTICLES, ON ITS APPROACH USING ICE COLD-PCR LIQUID BIOPSY TESTS ON REAL TIME PCR PLATFORMS ‍​ Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

Apr 03 2018

BRIEF-Precipio - Announces Laboratory Services Agreement With Core Diagnostics

* PRECIPIO - ANNOUNCES LABORATORY SERVICES AGREEMENT WITH CORE DIAGNOSTICS FOR ICE COLD-PCR LIQUID BIOPSY TESTING SERVICES IN INDIA, OTHER ASIAN COUNTRIES

Mar 26 2018

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF235.15 +0.10
Roche Holding Ltd. (RO.S) CHF235.40 -1.20
Sanofi SA (SASY.PA) €74.50 -0.17
Qiagen NV (QGEN.N) $37.47 -0.83
Sequenom, Inc. (SQNM.OQ) -- --
Merck KGaA (MRCG.DE) €87.16 +0.46

Earnings vs. Estimates